ArticleCancer immunology, immunotherapy : CII2012

Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma.

Jun Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.